Access cutting-edge transthyretin amyloidosis treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access transthyretin amyloidosis specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related transthyretin amyloidosis treatment provided free
Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque- like substance that accumulates in different organs in the body and can cause damage to the organ. There are two ways that the TTR protein can fall apart. One way occurs as a person ages, where the normal TTR protein can fall apart and form amyloid that may no longer be sufficiently cleared by the body. This type of ATTR is known as wild-type ATTR
Sponsor: Eidos Therapeutics, a BridgeBio company
Check if you qualify for this transthyretin amyloidosis clinical trial in Aurora, CO
If you're searching for transthyretin amyloidosis treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced transthyretin amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.